Profusa Inc. (PFSA): Kapitalisasi marang pendapatan

Simbol lan logo merek Profusa Inc. (PFSA)

The P/S ratio chart for Profusa Inc (PFSA) demonstrates the impact of current demand for oxygen sensors, while 0.00 reflects the metric's baseline. The asset's value growth is based on a unique technology for integrating sensors into body tissues. However, high operating losses and challenges with FDA approval create overvaluation risks, which are critical to consider when analyzing market capitalization relative to revenue.

PFSA Multiplikator P/S Profusa Inc. (15.07.2025 - 15.07.2025)

Rincian analitis perusahaan Profusa, Inc. (PFSA)

- rega saham lan konsensus proyeksi valuasi:
Analisis umum perusahaan:PFSA profusa.com
Barang utama Profusa Inc

Investing in Profusa Inc (PFSA) requires rigorous fundamental analysis to assess the fairness of its market value. The P/S ratio compares market capitalization to annual revenue, determining the price of one dollar of income and the risk of overpayment. By analyzing historical P/S levels, an investor can track the valuation trend of the business relative to its operational successes. The high value of human capital in biosensor development justifies a premium valuation of the issuer's equity.

Pesaing Profusa Inc

DXCM (dexcom.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Penumbra PEN|NOVT - Kapitalisasi marang pendapatan|Haemonetics Corp. - Multiplikator P/S|Rega marang dodolan Inspire Medical Systems Inc|PRCT: Multiplikator P/S|Rasio kapitalisasi marang pendapatan CNMD|PLSE (Pulse Biosciences) - Multiplikator P/S|InMode Ltd (INMD) - Koefisien rega marang pendapatan|Multiplikator P/S PMI|Kapitalisasi marang pendapatan Surmodics Inc. SRDX|Multiplikator P/S SENS (Senseonics Holdings)|Multiplikator P/S neuropace.com NPCE|TCMD - Rasio rega marang pendapatan|SNWV: Rasio rega marang pendapatan|OM (Outset) - Kapitalisasi marang pendapatan|Electromed - Rasio kapitalisasi pasar marang pendapatan|LNSR (LENSAR, Inc.) - Multiplikator P/S|Rega marang dodolan avitamedical.com RCEL|Rasio rega marang pendapatan Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Multiplikator rega marang pendapatan|EDAP TMS - Kapitalisasi marang pendapatan|Multiplikator P/S Apyx Medical Corp APYX|IceCure Medical, Ltd. - Multiplikator P/S|Koefisien rega marang pendapatan Pulmonx Corporation LUNG|telabio.com (TELA) - Rasio rega marang pendapatan|Rasio rega marang dodolan CTSO (CytoSorbents Corporation)|Rasio rega marang pendapatan Sensus Healthcare Corp|Kapitalisasi marang pendapatan Zynex Corp (ZYXI)|Multiplikator P/S ECOR|RBOT - Rega marang dodolan|Rasio rega marang pendapatan Inspira Technologies IINN|ICU: Rasio kapitalisasi marang pendapatan|IRIX: Kapitalisasi marang pendapatan|Intelligent Bio Solutions - Kapitalisasi marang volume dodolan|beyondair.net (XAIR) - Rasio rega marang pendapatan|Rasio rega marang dodolan SSKN (STRATA Skin Sciences, Inc.)|Rasio rega marang pendapatan GlucoTrack, Inc.|NAOV: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Venus Concept Corp (VERO)|NUWE - Rega marang dodolan|Multiplikator P/S AEMD (Aethlon Medical)|ASXC (Asensus Surgical Inc) - Rasio rega marang dodolan|AVGR: Kapitalisasi marang pendapatan|BSGM - Multiplikator P/S|Cutera, Inc (CUTR) - Rasio rega marang pendapatan|KNW - Koefisien rega marang pendapatan|NARI (Inari Medical, Inc.) - Multiplikator P/S|Multiplikator P/S nevro.com|Kapitalisasi marang pendapatan RSLS (ReShape Lifesciences)|SILK (Silk Road Medical, Inc.) - Rasio kapitalisasi pasar marang pendapatan